The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients

IntroductionThe COVID-19 pandemic dramatically disrupts health care for patients with chronic diseases including chronic spontaneous urticaria (CSU). As of now, it is unknown if the effects of the pandemic in CSU are different than in other chronic diseases. We also do not know, if different groups...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huzeyfe Kulu, Mustafa Atasoy, Kemal Özyurt, Marcus Maurer, Atıl Avcı, Muhammet Reşat Akkuş, Ragıp Ertaş
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/2235f84cafb444e08816173bda9b54e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2235f84cafb444e08816173bda9b54e6
record_format dspace
spelling oai:doaj.org-article:2235f84cafb444e08816173bda9b54e62021-11-04T11:44:21ZThe COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients1664-322410.3389/fimmu.2021.722406https://doaj.org/article/2235f84cafb444e08816173bda9b54e62021-10-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.722406/fullhttps://doaj.org/toc/1664-3224IntroductionThe COVID-19 pandemic dramatically disrupts health care for patients with chronic diseases including chronic spontaneous urticaria (CSU). As of now, it is unknown if the effects of the pandemic in CSU are different than in other chronic diseases. We also do not know, if different groups of CSU patients, for example female and male patients, are affected differently.AimTo understand how CSU patients and subgroups are affected by the COVID-19 pandemic in their disease activity and control and treatment, using psoriasis as control.Patients and MethodsWe analyzed 399 patients (450 visits) with CSU or psoriasis assessed during August 2019, i.e. before the pandemic, or August 2020, i.e. during the pandemic, for changes in disease activity, disease control, and the treatment they used, and how these changes are linked to age, gender, and disease duration.ResultsMale but not female patients with CSU had markedly increased disease activity during the pandemic. CSU patients’ age or disease duration were not linked to changes. Male and female patients with psoriasis showed similar increases in disease activity and decreases in disease control. The rate of omalizumab treatment, during the pandemic, was unchanged in male patients and increased in female patients with CSU. The efficacy of omalizumab treatment, during the pandemic, was reduced in male patients but not female patients with CSU.ConclusionMale but not female CSU patients, during the COVID-19 pandemic, show loss of disease control linked to loss of omalizumab efficacy. The reasons for this need to be investigated.Huzeyfe KuluMustafa AtasoyKemal ÖzyurtMarcus MaurerAtıl AvcıMuhammet Reşat AkkuşRagıp ErtaşFrontiers Media S.A.articlechronic spontaneous urticariachronic skin diseasesCOVID-19psoriasispandemic (COVID19)Immunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic chronic spontaneous urticaria
chronic skin diseases
COVID-19
psoriasis
pandemic (COVID19)
Immunologic diseases. Allergy
RC581-607
spellingShingle chronic spontaneous urticaria
chronic skin diseases
COVID-19
psoriasis
pandemic (COVID19)
Immunologic diseases. Allergy
RC581-607
Huzeyfe Kulu
Mustafa Atasoy
Kemal Özyurt
Marcus Maurer
Atıl Avcı
Muhammet Reşat Akkuş
Ragıp Ertaş
The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients
description IntroductionThe COVID-19 pandemic dramatically disrupts health care for patients with chronic diseases including chronic spontaneous urticaria (CSU). As of now, it is unknown if the effects of the pandemic in CSU are different than in other chronic diseases. We also do not know, if different groups of CSU patients, for example female and male patients, are affected differently.AimTo understand how CSU patients and subgroups are affected by the COVID-19 pandemic in their disease activity and control and treatment, using psoriasis as control.Patients and MethodsWe analyzed 399 patients (450 visits) with CSU or psoriasis assessed during August 2019, i.e. before the pandemic, or August 2020, i.e. during the pandemic, for changes in disease activity, disease control, and the treatment they used, and how these changes are linked to age, gender, and disease duration.ResultsMale but not female patients with CSU had markedly increased disease activity during the pandemic. CSU patients’ age or disease duration were not linked to changes. Male and female patients with psoriasis showed similar increases in disease activity and decreases in disease control. The rate of omalizumab treatment, during the pandemic, was unchanged in male patients and increased in female patients with CSU. The efficacy of omalizumab treatment, during the pandemic, was reduced in male patients but not female patients with CSU.ConclusionMale but not female CSU patients, during the COVID-19 pandemic, show loss of disease control linked to loss of omalizumab efficacy. The reasons for this need to be investigated.
format article
author Huzeyfe Kulu
Mustafa Atasoy
Kemal Özyurt
Marcus Maurer
Atıl Avcı
Muhammet Reşat Akkuş
Ragıp Ertaş
author_facet Huzeyfe Kulu
Mustafa Atasoy
Kemal Özyurt
Marcus Maurer
Atıl Avcı
Muhammet Reşat Akkuş
Ragıp Ertaş
author_sort Huzeyfe Kulu
title The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients
title_short The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients
title_full The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients
title_fullStr The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients
title_full_unstemmed The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients
title_sort covid-19 pandemic affects male patients with chronic spontaneous urticaria more than female patients
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/2235f84cafb444e08816173bda9b54e6
work_keys_str_mv AT huzeyfekulu thecovid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT mustafaatasoy thecovid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT kemalozyurt thecovid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT marcusmaurer thecovid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT atılavcı thecovid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT muhammetresatakkus thecovid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT ragıpertas thecovid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT huzeyfekulu covid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT mustafaatasoy covid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT kemalozyurt covid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT marcusmaurer covid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT atılavcı covid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT muhammetresatakkus covid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
AT ragıpertas covid19pandemicaffectsmalepatientswithchronicspontaneousurticariamorethanfemalepatients
_version_ 1718444886651305984